Related Experiment Video
Updated: Jan 25, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Identification of a putative competitive endogenous RNA network for lung adenocarcinoma using TCGA datasets
Yuanyong Wang1, Tong Lu1, Yang Wo1
1Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Abstract:
The mechanisms underlying the oncogenesis and progression of lung adenocarcinoma (LUAD) are currently unclear. The discovery of competitive endogenous RNA (ceRNA) regulatory networks has provided a new direction for the treatment and prognosis of patients with LUAD. However, the mechanism of action of ceRNA in LUAD remains elusive. In the present study, differentially expressed mRNAs, microRNAs (miRs) and long non-coding RNAs from the cancer genome atlas database were screened. CeRNAs for LUAD were then identified using online prediction software. Among the ceRNAs identified, family with sequence similarity 83 member A (FAM83A), miR-34c-5p, KCNQ1OT1 and FLJ26245 were observed to be significantly associated with the overall survival of patients with LUAD. Of note, FAM83A has potential significance in drug resistance, and may present a candidate biomarker for the prognosis and treatment of patients with LUAD.
Insights
This study identifies key regulatory networks in lung adenocarcinoma (LUAD) using competitive endogenous RNA (ceRNA) analysis. It highlights FAM83A as a potential biomarker for LUAD prognosis and drug resistance, offering new therapeutic avenues.
Area of Science:
- Molecular Biology
- Oncology
- Genomics
Background:
- The mechanisms of lung adenocarcinoma (LUAD) oncogenesis and progression are not fully understood.
- Competitive endogenous RNA (ceRNA) regulatory networks offer a novel approach for LUAD treatment and prognosis.
- The precise role of ceRNA in LUAD requires further elucidation.
Purpose of the Study:
- To identify and characterize ceRNA networks involved in LUAD.
- To investigate the association of specific ceRNAs with patient survival and drug resistance.
- To explore potential biomarkers for LUAD prognosis and treatment.
Main Methods:
- Screening of differentially expressed mRNAs, microRNAs (miRs), and long non-coding RNAs from The Cancer Genome Atlas (TCGA) database.
- Identification of LUAD-specific ceRNAs using online prediction software.
- Statistical analysis to determine the association of identified ceRNAs with overall survival in LUAD patients.
Main Results:
- Several ceRNAs were identified in LUAD.
- Family with sequence similarity 83 member A (FAM83A), miR-34c-5p, KCNQ1OT1, and FLJ26245 were significantly associated with overall survival in LUAD patients.
- FAM83A demonstrated potential significance in drug resistance.
Conclusions:
- The identified ceRNAs play a crucial role in LUAD progression.
- FAM83A is a promising candidate biomarker for LUAD prognosis and drug resistance.
- Further research into ceRNA networks could lead to improved LUAD treatment strategies.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Related Concept Videos
Competition
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Lung Capacity
RNA Polymerase II Accessory Proteins
RNA Stability